Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach and tens of thousands of employees belie its humble origins. Founded in 1980 as Applied ...
Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...
Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...
Natural products are small molecules produced naturally by any organism including primary and secondary metabolites. They include very small molecules, such as urea, and complex structures ...
Aligning kidney function assessment in patients with cancer to global practices in internal medicine
Copyright: © 2025 The Authors. Published by Elsevier Ltd. Development of the ADDIKD guideline is funded by the Cancer Institute NSW as part of the NSW Government and ...
As of 2:14:44 p.m. EDT. Market Open. Loading Chart for AMGN ...
Xtrackers S&P 500 Swap UCITS ETF - 1C USD ACC 23% SPDR S&P 500 UCITS ETF - USD DIS 23% ...
After hours: 24 March at 19:42:09 GMT-4 Loading Chart for AMGN ...
LD received a Kidney star grant from the Amercian Society of Nephrology to participate in the ASN kidney ... Sanofi and Janssen and honoraria for lectures from BMS, Sanofi, and Amgen. A.H.H is Member ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback